XRAY - DENTSPLY SIRONA Inc. Stock Analysis | Stock Taper
Logo
DENTSPLY SIRONA Inc.

XRAY

DENTSPLY SIRONA Inc. NASDAQ
$14.68 15.50% (+1.97)

Market Cap $2.93 B
52w High $17.18
52w Low $9.85
Dividend Yield 5.71%
Frequency Quarterly
P/E -3.34
Volume 12.67M
Outstanding Shares 199.55M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $961M $175M $-145M -15.09% $-0.73 $-32M
Q3-2025 $904M $392M $-427M -47.23% $-2.14 $-114M
Q2-2025 $936M $618M $-45M -4.81% $-0.23 $-41M
Q1-2025 $879M $403M $20M 2.28% $0.1 $142M
Q4-2024 $905M $955M $-430M -47.51% $-2.16 $-419M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $326M $5.43B $4.09B $1.34B
Q3-2025 $363M $5.65B $4.17B $1.48B
Q2-2025 $359M $6.07B $4.11B $1.96B
Q1-2025 $398M $6.05B $4.04B $2.01B
Q4-2024 $272M $5.75B $3.81B $1.94B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $-145M $101M $-45M $-99M $-37M $60M
Q3-2025 $-427M $79M $-36M $-36M $4M $40M
Q2-2025 $-45M $48M $-34M $-68M $-39M $16M
Q1-2025 $19M $7M $-17M $123M $126M $-12M
Q4-2024 $-428M $87M $-57M $-38M $-24M $36M

Revenue by Products

Product Q2-2022Q3-2022Q4-2022Q1-2023
Consumables Segment
Consumables Segment
$430.00M $390.00M $380.00M $430.00M
Technologies And Equipment
Technologies And Equipment
$590.00M $560.00M $600.00M $550.00M

Revenue by Geography

Region Q1-2025Q2-2025Q3-2025Q4-2025
Europe
Europe
$360.00M $400.00M $380.00M $430.00M
Other Foreign
Other Foreign
$210.00M $240.00M $230.00M $240.00M
UNITED STATES
UNITED STATES
$300.00M $290.00M $290.00M $300.00M

Q4 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at DENTSPLY SIRONA Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Key positives include a strong revenue base, attractive gross margins, and a leading position in digital dental technology. The company enjoys broad product coverage, a powerful brand, and a sticky, integrated ecosystem that ties together equipment, software, and consumables. Liquidity is adequate, and the business continues to generate positive operating and free cash flow even in a loss-making year. Its sustained investment in innovation positions it well for ongoing shifts toward digital and AI-driven dentistry.

! Risks

Major risks center on profitability and leverage. High overhead and non-operating costs have driven a large net loss, and cumulative negative retained earnings highlight historical challenges in turning scale into lasting earnings. Elevated debt levels increase financial risk and may limit flexibility if conditions deteriorate. Continued dividend payments despite losses can further strain the balance sheet. Externally, intense competition, fast-moving technology, and regulatory and economic pressures in healthcare add uncertainty to future performance.

Outlook

The company’s long-term prospects hinge on whether it can align its strong strategic and technological position with a leaner, more efficient financial profile. If management can control costs, simplify operations, and gradually deleverage while continuing to advance its digital ecosystem, the business could move from a story of under-earning to one of monetizing its innovations more fully. Until there is clearer evidence of sustained margin improvement and better retention of profits, however, the outlook remains balanced between the promise of its market position and the constraints of its current financial profile.